S. Karger AG

SHERPA: Unknown

People

  1. Bodei
    Bodei
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Abou-Alfa
    Abou-Alfa
  5. Chaganti
    Chaganti
  6. Lin
    Lin
  7. Tang
    Tang
  8. Clarkson
    Clarkson
  9. Janjigian
    Janjigian
  10. Marghoob
    Marghoob

Groups

  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)
  7. Sloan Kettering Institute Postdocs (55)
  8. Surgery (54)
  9. Sloan Kettering Institute Faculty (47)
  10. Thoracic Oncology (45)
Search Within
Formats
  1. Meeting Abstract (332)
  2. Journal Article (254)
  3. Book Section (20)
  4. Review (15)
  5. Conference Paper (10)
  6. Book Whole (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)

More Groups

People
  1. Lisa Bodei (32)
  2. Alexander Drilon (23)
  3. Robert Motzer (23)
  4. Ghassan Abou-Alfa (18)
  5. Steven Hajdu (18)
  6. Oscar Lin (16)

More People

Years
  1. 2025 (3)
  2. 2024 (21)
  3. 2023 (37)
  4. 2022 (42)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Oncology Research and Treatment (226)
  2. Cytogenetics and Cell Genetics (61)
  3. Acta Cytologica (58)
  4. Neuroendocrinology (51)
  5. Acta Haematologica (32)
  6. Onkologie (19)

More Publications

Results (633)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment-free remission (TFR) in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
    Meeting Abstract

    Saussele, S.; Shah, N.; García-Gutiérrez, J. V.; Jiménez-Velasco, A.; Larson, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Pane, F.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Efficacy of larotrectinib in TRK fusion cancer in adults and children
    Meeting Abstract

    Blattmann, C.; Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Hypogonadism in girls after cancer therapy: Causes, diagnosis, and treatment
    Meeting Abstract

    Sklar, C.
    Hormone Research in Paediatrics (2018)

    Fulltext@MSK | Save
  • Quality of life in patients with advanced renal cell carcinoma in the randomized, open-label CheckMate 214 trial
    Meeting Abstract

    Grnüwald, V.; Cella, D.; Escudier, B. J.; Hammers, H. J.; George, S.; Nathan, P.; Grimm, M. O.; Rini, B. I.; Doan, J.; Ivanescu, C.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels
    Meeting Abstract

    Brümmendorf, T. H.; Hochhaus, A.; Isfort, S.; le Coutre, P.; Jentsch-Ullrich, K.; Schafhausen, P.; Gambacorti-Passerini, C.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • IMmotion151: A randomized phase III study of atezolizumab plus bevacizumab vs sunitinib in untreated metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Grüllich, C.; Motzer, R. J.; Powles, T.; Atkins, M.; Escudier, B. J.; McDermott, D.; Suarez, C.; Bracarda, S.; Stadler, W.; Donskov, F.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Clinical use of Lanreotide AG as initial therapy in patients with advanced, non-resectable well (G1) and moderate (G2) differentiated pancreatic neuroendocrine neoplasms (p-NEN)
    Meeting Abstract

    Cwikla, J.; Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Palucki, J.; Roszkowska-Purska, K.; Kidd, M.; Bodei, L.; Modlin, I.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Efficacy of Octreotide LAR in treatment of naive patients with advanced, non-resectable well and moderate differentiated pancreatic neuroendocrine neoplasms (p-NENs)
    Meeting Abstract

    Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Bednarczuk, T.; Palucki, J.; Roszkowska-Purska, K.; Cichocki, A.; Dobkowski, P.; Kidd, M.; Bodei, L.; Modlin, I.; more...
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • PRRT in hindgut and cancer of unknown primary NEN
    Meeting Abstract

    Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Cichocki, A.; Roszkowska-Purska, K.; Dobkowski, P.; Bodei, L.; Cwikla, J.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Value of somatostatin receptor scintigraphy (SRS) in patients with appendiceal neuroendocrine neoplasms (ANEN) based on clinical follow-up and results of NETest
    Meeting Abstract

    Konsek, S.; Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Kidd, M.; Buscombe, J. R.; Bodei, L.; Cichocki, A.; Cwikla, J.; Modlin, I.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save